News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
140 Results
Type
Article (11)
Press Release (129)
Section
Business (37)
Deals (4)
Drug Development (3)
FDA (11)
Job Trends (4)
News (58)
Policy (7)
Tag
Academia (1)
Alliances (9)
Approvals (11)
Best Places to Work (3)
Clinical research (2)
Diagnostics (7)
Earnings (18)
Events (12)
FDA (11)
Government (1)
Healthcare (19)
Job creations (1)
Medical device (4)
Medtech (4)
Mergers & acquisitions (4)
NextGen Class of 2024 (2)
People (9)
Phase I (2)
Phase II (1)
Phase III (1)
Real estate (1)
Regulatory (6)
Research institute (1)
Date
Last 365 days (3)
2024 (1)
2023 (17)
2022 (21)
2021 (20)
2020 (15)
2019 (12)
2018 (10)
2017 (12)
2016 (6)
2015 (8)
2014 (5)
2013 (5)
Location
Asia (6)
Europe (61)
140 Results for "guerbet".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GUERBET : H1 2024 revenue.
July 26, 2024
·
6 min read
Business
Guerbet: First-half 2023 revenue
Guerbet, a global specialist in contrast agents and solutions for medical imaging, is reporting its revenue for the first half of 2023.
July 20, 2023
·
9 min read
Guerbet: Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer
Guerbet is delighted to announce the success of its teams at the PI-CAI Grand Challenge1, an international challenge organised by a consortium2 of radiology opinion leaders in prostate imaging, urologists and artificial intelligence experts, to compare the performance of artificial intelligence algorithms in the detection of prostate cancer.
July 17, 2023
·
5 min read
Pharm Country
Guerbet to Spotlight Diagnostic and Interventional Solutions at the 2023 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting
Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced its schedule of activities at the 2023 Radiological Society of North America Scientific Assembly and Annual Meeting from November 26-30 in Chicago, IL.
November 2, 2023
·
12 min read
Guerbet: 2022 annual results
Guerbet, a global specialist in contrast agents and solutions for medical imaging, has published its consolidated financial statements for the 2022 fiscal year.
March 22, 2023
·
8 min read
Business
Guerbet: 2022 revenue
Guerbet, a global specialist in contrast agents and solutions for medical imaging, has reported its annual revenue.
February 9, 2023
·
6 min read
Guerbet: 2023 Strategic Priorities
Guerbet, a global specialist in contrast agents and solutions for medical imaging has announced its strategic priorities for 2023 in a complex international environment characterised by persistent inflationary pressures and the revelation of new business opportunities for products listed in developing markets.
January 16, 2023
·
6 min read
Pharm Country
Guerbet Announces ACR Committee on Drugs and Contrast Media Classifies Elucirem™ (Gadopiclenol) Injection a Group II Agent
Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced today that based on the most recent scientific and clinical evidence, the ACR Committee on Drugs and Contrast Media has classified Elucirem™ (gadopiclenol) as a Group II agent.
May 9, 2023
·
10 min read
Business
Guerbet: Revenue at September 30, 2022
Guerbet, a global specialist in contrast agents and solutions for medical imaging, reported its revenue for the first 9 months of 2022.
October 20, 2022
·
7 min read
Guerbet: 2022 half-year results
Villepinte, Wednesday, September 21, 2022: Guerbet, a global specialist in contrast agents and solutions for medical imaging, is announcing its consolidated results for the first half of 2022.
September 21, 2022
·
9 min read
1 of 14
Next